Traverse — What's New

A record of every meaningful change shipped to Traverse. Sorted newest first. For the App Store version-history view, see the App Store listing.

v1.0 — First public release

30 June 2026

Traverse v1.0 ships today. This is the first version available outside of internal testing.

What this release brings:

• Seven new conditions: COPD, asthma, heart failure (stable, medicated), hyperthyroidism, iron-deficiency anaemia, menopause/perimenopause, and atrial fibrillation (medicated). Each declared via onboarding, each recalibrating your baselines against published clinical thresholds.
• New manual-entry surfaces for the values that matter to those conditions — spirometry, thyroid panel, full iron studies, reproductive hormones, regimen tracking, INR, and cardiac assessments.
• New chart canvases for the metrics with continuous trajectories (peak flow, INR) and daily counts (vasomotor flushes, oxygen therapy adherence, reliever inhaler use). Each anchored to a research-backed reference, described not evaluated.
• HealthKit passive synchronisation for FEV1, six-minute walk distance, peak flow, and inhaler usage. Manual entry remains available for everything else.
• Evidence-strength voice tiers: thresholds now carry a strong/moderate/directional classification. The voice differentiates accordingly — confident for strong evidence, hedged for moderate, orientation-only for directional.
• Onboarding visibility: the conditions you don't declare don't appear. Categories and chart pickers gate to your declared profile, so you see what's relevant to you.

What we deliberately did not ship:

• Clinical decision instruments computed from your inputs (CHA₂DS₂-VASc and HAS-BLED can be logged from values your clinician calculated, but Traverse does not compute them).
• Free-text input fields. Every input is a selected option or a numerical value with units.
• Ads. Tracking. Analytics SDKs. Data resale of any kind. We don't have them and won't add them.

This is the first version. The voice will be refined; the chart system will be polished; v1.1 is being planned. If you have feedback, write to us at support@adfinium.co.uk — we read everything.